Russian Experience of Bosutinib Use in Chronic Myeloid Leukemia Patients in Routine Clinical Practice

被引：0

作者：

Shuvaev, Vasily ^{[1
]}

Vinogradova, Olga ^{[2
,3
,4
]}

Martynkevich, Irina ^{[1
]}

Natalya, Novitskaya ^{[2
]}

Fominykh, Mikhail ^{[5
]}

Tsareva, Svetlana ^{[6
]}

Shikhbabaeva, Dzhariyat ^{[2
]}

Pankrashkina, Maria ^{[2
,3
]}

Chernikov, Mikhail ^{[2
]}

Sharkunov, Nikolay ^{[2
]}

Zotova, Irina ^{[5
]}

Udaleva, Vera ^{[5
]}

Motyko, Ekaterina ^{[5
]}

Voloshin, Sergei ^{[1
,7
,8
]}

机构：

[1] Fed Med Biol Agcy, Russian Sci Res Inst Hematol & Transfusiol, Fed State Budget Inst, St Petersburg, Russia

[2] Botkin City Clin Hosp, Hematol Moscow City Ctr, Moscow, Russia

[3] Dmitry Rogachev Natl Res Ctr Pediat Hematol Oncol, Moscow, Russia

[4] Pirogov Russian Natl Res Med Univ, Moscow, Russia

[5] Russian Res Inst Hematol & Transfusiol, St Petersburg, Russia

[6] Botkin City Hosp, Hematol Moscow City Ctr, Moscow, Russia

[7] Mil Med Acad, St Petersburg, Russia

[8] North Western State Med Univ, St Petersburg, Russia

来源：

BLOOD | 2018年 / 132卷

关键词：

D O I：

10.1182/blood-2018-99-114164

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

5446

引用

页数：3

共 50 条

[31] Incidence and evaluation of predisposition to cardiovascular toxicity in chronic myeloid leukemia patients treated with bosutinib in the real-life practice
Caocci, Giovanni
Mulas, Olga
Abruzzese, Elisabetta
Iurlo, Alessandra
Annunziata, Mario
Orlandi, Ester Maria
Galimberti, Sara
Binotto, Gianni
Sgherza, Nicola
Luciano, Luigia
Martino, Bruno
Rossi, Antonella Russo
Bonifacio, Massimiliano
Fozza, Claudio
Trawinska, Malgorzata Monika
Cattaneo, Daniele
Elena, Chiara
Barate, Claudia
De Gregorio, Fiorenza
Molica, Matteo
La Nasa, Giorgio
Foa, Robin
Breccia, Massimo
ANNALS OF HEMATOLOGY, 2019, 98 (08) : 1885 - 1890
[32] MAINTENANCE OF THE RUSSIAN REGISTER OF THE PATIENTS WITH CHRONIC MYELOID LEUKEMIA
Vinogradova, O. Yu.
Lazareva, O. V.
Kulikov, S. M.
Chemikov, M. V.
Turkina, A. G.
GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2010, 55 (02): : 13 - 29
[33] Russian register of patients with chronic myeloid leukemia.
Turkina, A. G.
Vinogradova, O. Yu.
Khoroshko, N. D.
Vorobyov, A. I.
GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2007, 52 (02): : 7 - 11
[34] Real Life Evaluation of Efficacy and Safety of Bosutinib Therapy in Chronic Myeloid Leukemia Patients
Attolico, Imma
Latagliata, Roberto
Breccia, Massimo
Abruzzese, Elisabetta
Iurlo, Alessandra
Capodanno, Isabella
Annunziata, Mario
Galimberti, Sara
Tiribelli, Mario
Martino, Bruno
Gozzini, Antonella
Scortechini, Anna Rita
Elena, Chiara
Castagnetti, Fausto
Luciano, Luigia
Fava, Carmen
Pregno, Patrizia
Stagno, Fabio
Bergamaschi, Micaela
Binotto, Gianni
Bonifacio, Massimiliano
Caocci, Giovanni
Crugnola, Monica
Tarantini, Francesco
Specchia, Giorgina
Albano, Francesco
BLOOD, 2018, 132
[35] Inflammatory/Immune Adverse Events in Chronic Myeloid Leukemia Patients During Treatment With Bosutinib
Agostani, E.
Tassistro, E.
Antolini, L.
Gambacorti-Passerini, C.
CANCER MEDICINE, 2025, 14 (03):
[36] Safety and efficacy of bosutinib in fourth-line therapy of chronic myeloid leukemia patients
Garcia-Gutierrez, Valentin
Milojkovic, Dragana
Carlos Hernandez-Boluda, Juan
Claudiani, Simone
Martin Mateos, Maria Luisa
Felipe Casado-Montero, Luis
Gonzalez, Gloria
Jimenez-Velasco, Antonio
Boque, Concepcion
Martinez-Trillos, Alejandra
Mata Vazquez, Isabel
Ramirez Payer, Angel
Senin, Alicia
Amustio Diez, Elena
Barez Garcia, Abelardo
Bautista Carrascosa, Guiomar
Orti, Guillermo
Cuevas Ruiz, Beatriz
Angeles Fernandez, Maria
Garcia Garay, Maria del Carmen
Giraldo, Pilar
Maria Guinea, Jose
De las Heras Rodriguez, Natalia
Hernan, Nuria
Iglesias Perez, Ana
Piris-Villaespesa, Miguel
Lopez Lorenzo, Jose Luis
Marti Marti-Tutusaus, Josep Maria
Omar Vallansot, Rolando
Ortega Rivas, Fernando
Manuel Puerta, Jose
Jose Ramirez, Maria
Romero, Esperanza
Romo, Andres
Rosell, Ana
Saavedra Saavedra, Silvanna
Sebrango, Ana
Tallon, Jose
Valencia, Sandra
Portero, Angeles
Luis Steegmann, Juan
ANNALS OF HEMATOLOGY, 2019, 98 (02) : 321 - 330
[37] Safety and efficacy of bosutinib in fourth-line therapy of chronic myeloid leukemia patients
Valentín García-Gutiérrez
Dragana Milojkovic
Juan Carlos Hernandez-Boluda
Simone Claudiani
María Luisa Martin Mateos
Luis Felipe Casado-Montero
Gloria González
Antonio Jimenez-Velasco
Concepcion Boque
Alejandra Martinez-Trillos
Isabel Mata Vázquez
Ángel Ramírez Payer
Alicia Senín
Elena Amustio Díez
Abelardo Bárez García
Guiomar Bautista Carrascosa
Guillermo Ortí
Beatriz Cuevas Ruiz
Maria Ángeles Fernández
María del Carmen García Garay
Pilar Giraldo
Jose María Guinea
Natalia De Las Heras Rodríguez
Nuria Hernán
Ana Iglesias Pérez
Miguel Piris-Villaespesa
Jose Luis López Lorenzo
Josep Maria Martí Martí-Tutusaus
Rolando Omar Vallansot
Fernando Ortega Rivas
Jose Manuel Puerta
Maria Jose Ramirez
Esperanza Romero
Andres Romo
Ana Rosell
Silvanna Saavedra Saavedra
Ana Sebrango
José Tallon
Sandra Valencia
Angeles Portero
Juan Luis Steegmann
Annals of Hematology, 2019, 98 : 321 - 330
[38] IMATINIB DISCONTINUATION IN CHRONIC MYELOID LEUKEMIA: A RETROSPECTIVE ANALYSIS ON PATIENTS IN CLINICAL PRACTICE
Rege-Cambrin, G.
Fava, C.
Dogliotti, I.
Berchialla, P.
Gottardi, E.
Cerrano, M.
Ferrero, D.
Nicolosi, M.
Pregno, P.
Orlandi, E.
Cattaneo, D.
Iurlo, A.
Catania, G.
Davide, R.
Saglio, G.
HAEMATOLOGICA, 2015, 100 : 232 - 232
[39] Phase 2 Study of Bosutinib in Japanese Patients with Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia
Takahashi, Naoto
Matsumura, Itaru
Fujisawa, Shin
Ishizawa, Kenichi
Ono, Takaaki
Sakaida, Emiko
Sekiguchi, Naohiro
Tanetsugu, Yusuke
Fukuhara, Kei
Ohkura, Masayuki
Koide, Yuichiro
Hino, Masayuki
BLOOD, 2019, 134
[40] Chronic myeloid leukemia in young patients: Experience in a clinical hematology unit in Senegal
Fall, S.
Ndiaye, F. S. D.
Dior, O. D.
Sall, A. F.
Sloma, I.
Toure-Fall, A.
Keita, Y.
REVUE D ONCOLOGIE HEMATOLOGIE PEDIATRIQUE, 2015, 3 (04): : 170 - 174

← 1 2 3 4 5 →